Owlet, Inc.

OWLT Healthcare Medical Devices

In the quarter to June 2026, revenue grew 29.9%, EPS grew 97.9%, free cash flow grew 55.7% and total debt fell 16.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

4.14 0.30 −6.76%
Market cap
$129.8M
P/E
0.0×
Fwd P/E
−13.0×
Dividend yield
—
F-score
4/9
Altman Z
−0.37
Beneish M
−3.37
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

3 4 3 5
ROE
110.04% 781.68% 1,991.45% 68.03%
ROA
(63.51%) (61.94%) (69.12%) (15.60%)
ROIC
0.00% (168.95%) (59.64%) (27.60%)
Return on Tangible Assets
(462.71%) (110.23%) (136.30%) (34.70%)
Average Days of Receivables
104.69 79.18 67.70 105.27
Free Cash Flow per Share
(0.49) (0.65) (0.41) (0.35)
Free Cash Flow
(7.96) (11.73) (11.16) (9.86)
Other line items

Show all line items

Columns are period end dates